InvestorsHub Logo
Followers 60
Posts 3926
Boards Moderated 0
Alias Born 01/16/2016

Re: Wangenstein post# 57994

Sunday, 04/23/2017 5:01:36 PM

Sunday, April 23, 2017 5:01:36 PM

Post# of 195721
AUDIT SHOWED DOUBLE-DIGIT YOY GROWTH MONTH AFTER MONTH

RXMD has had double-digit YoY revenue growth each month for the past year, up to and including March 2017.

Don't divide $22 million by four to get RXMD's quarterly revenue expectations, particularly when RXMD hasn't earned more than 23% of their annual revenue in Q1 in the past three years, and that in 2016 it was only 21%.

RXMD is growing, month after month, year after year; that the third-party-audited financials proved that RXMD's growth is real; and that we'll be seeing RXMD continue to grow for months and years to come.

RXMD's 2015 revenues were up 21% over 2014; that 2016's revenues were up 34% over 2015; or that Q1 2017 is on-track for RXMD to achieve its revenue goal of 20% YoY growth at $22 million.

Current revenues, RXMD should be trading at 5-7 cents right now, and will be sooner rather than later.

RXMD is a company that is growing, and a stock to buy and hold.

It's as simple as that.

RXMD

ALL IMO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News